Now I have sufficient calibration context. Let me produce the final review.

**Round 1 bracket:** I compared MOCHA against anchors spanning 1.0–8.0. The strongest match in bio-curation is "A Guide to Misinformation Detection Datasets" (3.50), which curated 75 datasets AND ran baselines AND evaluated quality — all steps MOCHA omits. The scMPT paper (3.40) had actual experiments (shallow but present). The score-1–2 anchors are incomplete/broken papers. MOCHA is more complete than those but lacks the validation that even score-3.5 curation papers provide.

**Narrowing to final score:** MOCHA has a real motivation and a concrete (but undescribed) resource in Table 1. But it has zero experiments, zero annotation characterization, generic filler content, and no data access. It is weaker than any curation/benchmark paper I found scoring ≥3.5, and stronger than incomplete papers scoring ≤2. The right score is 3.0.

Here is the final review:

---

## Summary

MOCHA is presented as a curated resource of 10 multi-subject spatial transcriptomics cohorts (spanning breast, colorectal, kidney, lung cancers, brain, and olfactory bulb; 1–94 subjects) with paired gene expression matrices, spatial coordinates, H&E images, and expert pathologist domain annotations. The paper claims this fills a gap in resources for developing and evaluating multi-sample SRT integration methods.

## Strengths

- **Table 1 documents a useful collection scope.** The table enumerates 10 cohorts spanning diverse tissue types, technologies (10x Visium, ST), and cohort sizes, specifying subjects and samples per cohort. This concrete catalog is the paper's one fully presented deliverable.
- **The identified gap is real.** The lack of multi-subject SRT datasets with expert spatial annotations does constrain method development for multi-sample integration, and a properly curated and documented resource addressing this would be valuable.

## Weaknesses

### Major

- **The annotations — the paper's entire value-add — are essentially undescribed in the main text.** The abstract promises "each sample paired with domain annotations from expert pathologists," but the main text provides almost nothing about them: no annotation protocol, no information about the pathologists (number, qualifications), no inter-annotator reliability check, no per-cohort breakdown of label sets or granularity (spot-level vs. region-level), and no resolution of how non-cancer datasets (DLPFC brain layers, MOB olfactory bulb) are annotated — the "immune, stroma, tumor, normal" framework (line 90) does not apply to them. The single substantive sentence references Supplementary Material without summarizing even basic statistics (number of labels, label frequencies, label distributions per cohort). For a dataset paper whose distinguishing feature is expert annotations, leaving the annotations as a black box prevents readers from evaluating whether the contribution has any value.

- **No experiments, benchmarks, or demonstrations that the resource works for its stated purpose.** The paper claims MOCHA is "for developing and evaluating multi-sample SRT methods" (Abstract) but never actually uses the resource: no baseline methods are run, no clustering or domain segmentation metrics are computed against the annotations, no annotation visualizations overlaid on tissue sections are shown, and no analysis of whether expert annotations are consistent with molecular profiles (e.g., differential expression across annotated domains) is provided. A dataset paper must at minimum demonstrate that the resource is usable and that the annotations support the evaluations it claims to enable; this paper does nothing of the sort.

### Minor

- **Sections 3 and 4 are generic textbook summaries that do not describe anything specific to MOCHA.** Section 3 surveys standard normalization methods (TMM, RLE, scater, scran, Seurat, scanpy), HVG selection, Harmony, and Crescendo without stating what preprocessing was actually applied to MOCHA data — or even whether the data is provided preprocessed or raw. Section 4 describes three existing methods (BayeSMART, BASS, STAGATE) in three sentences each. Together these occupy roughly half the paper's body text but contain no original content. This space should instead describe the curation pipeline, the annotation process, and dataset validation.

- **No data access information is provided.** The abstract states that MOCHA is "released in formats readily usable with Python and R and distributed for integration into existing pipelines," but no URL, DOI, Zenodo link, GitHub repository, or any access mechanism is given. A dataset paper is incomplete without specifying how to obtain the data, its file formats, and its licensing.

- **One cohort (MOB.ST) has only 1 subject** (12 samples from the same animal), which does not support multi-subject evaluation. This undermines the "multi-sample" framing for that specific cohort.

### Trivial

None.

## Nice-to-Haves

- Running BASS, BayeSMART, or STAGATE on 2–3 cohorts and reporting ARI/NMI against the expert annotations would immediately validate the resource's purpose.
- Visualizing annotations overlaid on H&E images for at least one section per cohort would be the single most informative figure for a dataset paper.
- A per-cohort table showing domain label names, frequencies, and mapping to the four broad categories (where applicable) would clarify the annotation landscape.

## Removed Points

These points are flagged to be removed; treat them with caution.

- **"Were the annotations newly produced or reproduced?"** — The paper states annotations come from the original publications (line 28: "required each study to provide... cellular annotations delineated by a pathologist"), though it remains ambiguous whether MOCHA adds newly produced annotations. This is a reasonable clarification question but not a confirmed flaw.
- **Criticism about missing appendix content or supplementary material** — These sections are stripped by the PDF parser; they exist in the original submission.
- **Formatting, grammar, and typo nitpicks** — These are parser artifacts, not author errors.
- **Generic "evaluation lacks rigor" / "could the metric be measuring a proxy" style concerns** — Not anchored to specific paper content.
- **Strength: "the paper identifies a genuine gap"** — Generic; the concrete strength (Table 1) is already listed.
- **Strength: "collection would be useful if properly curated"** — The hedging prevents this from being a genuine strength.

## Novel Insights

None beyond the paper's own contributions. The gap between the paper's ambition and its delivery is evident from the paper itself: the core contribution (annotations) is asserted but never characterized or validated. The reviews surface no additional unexpected insight.

## Suggestions

1. Substantially expand the annotation description in the main text: per-cohort label sets, counts, annotation protocol, pathologist qualifications, and inter-annotator agreement (if applicable).
2. Add at least 2–3 benchmark experiments using existing multi-sample methods (e.g., BASS, BayeSMART, STAGATE) to demonstrate that the annotations enable the evaluations the paper claims.
3. Replace Sections 3 and 4 with curation details, the preprocessing pipeline actually applied to MOCHA data, and annotation statistics.
4. Provide data access information (URL/DOI), file format specifications (AnnData, Seurat, etc.), and licensing.

## Score and Decision

I compared MOCHA against human-reviewed anchors. Key comparisons:

| Anchor path | Avg human score | Comparison |
|---|---|---|
| `P49gSPmrvN.md` (incomplete UMAP paper) | 1.00 | Much weaker; MOCHA at least has a complete structure and real curation effort |
| `5lUdTogEL3.md` (incomplete ReID paper) | 1.00 | Incomplete submission; not comparable |
| `nUpM7egYFd.md` (scMPT) | 3.40 | Had actual experiments (shallow but present); MOCHA lacks experiments entirely |
| `Jztt1nrjAM.md` (Misinformation dataset guide) | 3.50 | Curated 75 datasets AND ran baselines AND evaluated quality; MOCHA does none of these |
| `iOltCu4TPS.md` (Single-cell retrieval benchmark) | 5.00 | Evaluated 12 methods across 3 settings; MOCHA has zero evaluation |
| `0ApkwFlCxq.md` (ComputAgeBench) | 6.25 | Collected 66 datasets, tested 13 models, defined 4 tasks; far more complete |

**Round 1 bracket:** 2.5–4.0. The paper is more substantial than score-1–2 anchors (which are incomplete or broken) but substantially weaker than any curation/benchmark paper scoring ≥3.5, which all include some validation or experiments MOCHA lacks.

**Final score:** 3.0. The paper identifies a real need and documents a curation scope in Table 1. However, the annotations (the entire value-add) are essentially undescribed, no experiments demonstrate the resource works, roughly half the paper is generic filler, and no data access is provided. These are structural gaps, not minor presentation issues. The paper should be rejected with encouragement to resubmit a version that characterizes and validates the dataset.

MY FINAL SCORE: <score>3.0</score>
MY FINAL DECISION: <decision>Reject</decision>